interaction records 54 assistance programs 55 0 personal data stored
OmniRx › Tools › Generic competition check › Calcifediol

Generic competition · all medicines · read 12 November 2026

Is there a generic of Calcifediol, and who makes it?

Calcifediol appears in 2 dosage-form groups in the FDA Orange Book as of 12 November 2026, with no generic maker listed as marketed. 1 group has a brand listed as marketed and no generic listed as marketed. The data does not state why, and it does not state that one is coming. This is the Orange Book's listing, not a forecast.

Compiled and checked by Vincent Wesley Couey (ORCID 0009-0005-6869-308X) from the Orange Book data files, downloaded 12 November 2026.

Not medical advice. This page reports what the FDA's Orange Book lists, not what a pharmacy has in stock, what anything costs, or whether a generic is right for you. Ask your pharmacist or prescriber about your own medicine.
Calcifediol2 dosage-form groups in the Orange Book
0generic makers listed
  1. Calcifediol appears in 2 dosage-form groups in the FDA Orange Book as of 12 November 2026, with no generic maker listed as marketed.
  2. 1 group has a brand listed as marketed and no generic listed as marketed. The data does not state why, and it does not state that one is coming.
  3. Patents and exclusivities are shown as listed by the application holder; the Orange Book does not rule on them, and a listed patent is not a statement that a generic is blocked. This says nothing about price, supply or quality.

Capsule, Oral

Nothing listed as marketed

Every brand product here is listed as discontinued. No generic is listed as marketed.

Patents and exclusivities still listed

No unexpired patent or exclusivity is listed against the marketed brand products in this group.

Capsule, Extended Release, Oral

Brand listed, no generic listed as marketed

Brand listed as marketed: Rayaldee. No generic is listed as marketed.

2015202020252030203501brand 2016data datePatent 9943530 listed to expire 2 February 2027Patent 10213442 listed to expire 2 February 2027Patent 8906410 listed to expire 2 February 2027Patent 8778373 listed to expire 25 April 2028Patent 9408858 listed to expire 25 April 2028Patent 9925147 listed to expire 25 April 2028Patent 8207149 listed to expire 25 April 2028Patent 9498486 listed to expire 25 April 2028Patent 11154509 listed to expire 25 April 2028Patent 8361488 listed to expire 19 July 2028Patent 8426391 listed to expire 27 August 2028Patent 11801253 listed to expire 7 September 2030Patent 9861644 listed to expire 14 March 2034Patent 10300078 listed to expire 14 March 2034Patent 10357502 listed to expire 14 March 2034Patent 11253528 listed to expire 14 March 2034
generic makers listed as marketed, by first approvallisted patent expiryexclusivity end

Patents and exclusivities still listed

  • 2 February 2027Patent 9943530
  • 2 February 2027Patent 10213442 drug product
  • 2 February 2027Patent 8906410 drug product
  • 25 April 2028Patent 8778373
  • 25 April 2028Patent 9408858
  • 25 April 2028Patent 9925147 drug product
  • 25 April 2028Patent 8207149
  • 25 April 2028Patent 9498486

8 more patents are listed.

US Food and Drug Administration, Orange Book data files, downloaded 12 November 2026. A listed patent is not a ruling that a generic is blocked, and no figure here says anything about price, supply or quality. Check the Orange Book.

Where can you go from this result?

Open it in the check to search another medicine, or see every brand with no generic listed. The FDA explains generic approval in how generic drugs are approved and the FDA generic drug facts, and the Orange Book itself is the FDA Orange Book. To check what is available now, ask your pharmacist, and see the FDA drug shortages page.